Inactive Instrument

News Belluscura plc

Stocks

BELL

GB00BD3B8Z11

Medical Equipment, Supplies & Distribution

All News

22/09/25	Belluscura plc Announces Termination of Robert Rauker as Director, Effective September 22, 2025	CI
22/09/25	Belluscura plc Announces Termination of Appointment of Richard John Piper as Director, Effective September 22, 2025	CI
22/09/25	Belluscura plc Announces Termination of Appointment of Simon Neicheril as Director, Effective May 2, 2025	CI
22/09/25	Belluscura Unit Cuts 15 US Jobs Amid Refinancing Talks	MT
22/09/25	Belluscura says proposed fundraising talks not yet concluded as anticipated	RE
12/09/25	Belluscura plc Announces Appointment of Guy Peters as Non-Executive Director, Effective September 11, 2025	CI
11/08/25	Belluscura to Potentially Dispose of Certain Medical Assets, Liabilities; Loan Note Deal Terminated	MT
30/06/25	Belluscura Unit Obtains Short-term Convertible Loan Note	MT
30/06/25	Belluscura plc Provides Strategic Review Update	CI
13/05/25	Belluscura Says No New 'Notifiable Developments' as Shares Surge	MT
13/05/25	Belluscura notes share price rise, says no news since Friday	AN
09/05/25	Belluscura launches strategic review as seeks working capital boost	AN
09/05/25	AIM WINNERS & LOSERS: Conroy Gold hails Clontibret potential	AN
09/05/25	Belluscura Launches Strategic Review to Boost Capital Position	MT
09/05/25	Belluscura Announces Commencement Of Strategic Review	RE
09/05/25	Belluscura Commences Strategic Review	CI
16/04/25	Belluscura CFO to Step Down in May	MT
16/04/25	Medical device maker Belluscura expects 20% tariff on products sold in US	RE
16/04/25	Medical device maker Belluscura expects 20% tariff on products sold in US	RE
16/04/25	UK medical device maker Belluscura expects 20% tariff on products sold in US	RE
16/04/25	Belluscura Says CFO Simon Neicheril Resigns	RE
08/04/25	Belluscura withdraws 2025 outlook over U.S. tariff impact	RE
08/04/25	AIM WINNERS & LOSERS: Belluscura withdraws guidance on tariff fears	AN
08/04/25	Belluscura shares dive as withdraws market guidance amid US tariffs	AN
08/04/25	Belluscura Withdraws FY25 Guidance to Assess US Import Tariffs' Impact	MT